Elisabetta De Matteis

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Sabrina Chiara Cecere, Gaia Giannone, Vanda Salutari et al. · Gynecologic Oncology · 2019 · 106 citations · Full text

Medicine, Gynecology, Oncology +16

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation

Angela Toss, Giovanni Grandi, Angelo Cagnacci et al. · Oncotarget · 2016 · 43 citations · Full text

Medicine, Genetics, Oncology +17

Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening Program

Federica Sebastiani, Laura Cortesi, Milena Sant et al. · Journal of Breast Cancer · 2016 · 38 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women

Laura Cortesi, Elisabetta Razzaboni, Angela Toss et al. · Annals of Oncology · 2013 · 36 citations · Full text

Medicine, Genetics, Oncology +14

Identification of Protein Clusters Predictive of Response to Chemotherapy in Breast Cancer Patients

Laura Cortesi, Andrea Barchetti, Elisabetta De Matteis et al. · Journal of Proteome Research · 2009 · 35 citations

Life Sciences, Molecular Biology, Oncology +17